These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22488176)

  • 21. No increased risk of cardiovascular events in older adults initiating dipeptidyl peptidase-4 inhibitors vs therapeutic alternatives.
    Gokhale M; Buse JB; Jonsson Funk M; Lund J; Pate V; Simpson RJ; Stürmer T
    Diabetes Obes Metab; 2017 Jul; 19(7):970-978. PubMed ID: 28195389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone fracture risk is not associated with the use of glucagon-like peptide-1 receptor agonists: a population-based cohort analysis.
    Driessen JH; Henry RM; van Onzenoort HA; Lalmohamed A; Burden AM; Prieto-Alhambra D; Neef C; Leufkens HG; de Vries F
    Calcif Tissue Int; 2015 Aug; 97(2):104-12. PubMed ID: 25894068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thiazolidinediones were associated with higher risk of cardiovascular events in patients with type 2 diabetes and cirrhosis.
    Yen FS; Wei JC; Chiu LT; Hsu CC; Hou MC; Hwu CM
    Liver Int; 2021 Jan; 41(1):110-122. PubMed ID: 33124143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of acute myocardial infarction in patients treated with thiazolidinediones or other antidiabetic medications.
    Stockl KM; Le L; Zhang S; Harada AS
    Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):166-74. PubMed ID: 19109802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fracture risk associated with common medications used in treating type 2 diabetes mellitus.
    Wolverton D; Blair MM
    Am J Health Syst Pharm; 2017 Aug; 74(15):1143-1151. PubMed ID: 28743778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone as a target of type 2 diabetes treatment.
    Lecka-Czernik B
    Curr Opin Investig Drugs; 2009 Oct; 10(10):1085-90. PubMed ID: 19777397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone loss in diabetes: use of antidiabetic thiazolidinediones and secondary osteoporosis.
    Lecka-Czernik B
    Curr Osteoporos Rep; 2010 Dec; 8(4):178-84. PubMed ID: 20809203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture.
    Driessen JH; van Onzenoort HA; Henry RM; Lalmohamed A; van den Bergh JP; Neef C; Leufkens HG; de Vries F
    Bone; 2014 Nov; 68():124-30. PubMed ID: 25093264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thiazolidinediones and the risk of incident strokes in patients with type 2 diabetes: a nested case-control study.
    Azoulay L; Schneider-Lindner V; Dell'aniello S; Filion KB; Suissa S
    Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):343-50. PubMed ID: 19998318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcomes of basal insulin and oral antidiabetic agents as an add-on to dual therapy in patients with type 2 diabetes mellitus.
    Cheng CN; Wang CY; Lin HW; Chang TY; Lin HJ; Chou C; Lin FJ
    Sci Rep; 2020 Apr; 10(1):5746. PubMed ID: 32238842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of Fractures in Patients With Type 2 Diabetes in the SAVOR-TIMI 53 Trial.
    Mosenzon O; Wei C; Davidson J; Scirica BM; Yanuv I; Rozenberg A; Hirshberg B; Cahn A; Stahre C; Strojek K; Bhatt DL; Raz I
    Diabetes Care; 2015 Nov; 38(11):2142-50. PubMed ID: 26358285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs.
    Colhoun HM; Livingstone SJ; Looker HC; Morris AD; Wild SH; Lindsay RS; Reed C; Donnan PT; Guthrie B; Leese GP; McKnight J; Pearson DW; Pearson E; Petrie JR; Philip S; Sattar N; Sullivan FM; McKeigue P;
    Diabetologia; 2012 Nov; 55(11):2929-37. PubMed ID: 22945303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thiazolidinediones and fractures in men and women.
    Dormuth CR; Carney G; Carleton B; Bassett K; Wright JM
    Arch Intern Med; 2009 Aug; 169(15):1395-402. PubMed ID: 19667303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distal upper and lower limb fractures associated with thiazolidinedione use.
    Jones SG; Momin SR; Good MW; Shea TK; Patric K
    Am J Manag Care; 2009 Aug; 15(8):491-6. PubMed ID: 19670952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations Between Thiazolidinediones Use and Incidence of Rheumatoid Arthritis: A Retrospective Population-Based Cohort Study.
    Zhao H; Chen X; Sun Y; Shen P; Lin H; Sun F; Zhan S
    Arthritis Care Res (Hoboken); 2024 Apr; 76(4):486-496. PubMed ID: 38108108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lifetime risks of hip fracture in patients with type 2 diabetic: Taiwan Diabetes Study.
    Lin CC; Li CI; Liu CS; Wang MC; Lin CH; Lin WY; Yang SY; Li TC
    Osteoporos Int; 2021 Dec; 32(12):2571-2582. PubMed ID: 34230998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis.
    Rajagopalan R; Rosenson RS; Fernandes AW; Khan M; Murray FT
    Clin Ther; 2004 Sep; 26(9):1400-10. PubMed ID: 15531002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Do thiazolidinediones harm skeletal integrity?].
    Takeuchi Y
    Clin Calcium; 2008 May; 18(5):650-5. PubMed ID: 18445884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes.
    Aubert RE; Herrera V; Chen W; Haffner SM; Pendergrass M
    Diabetes Obes Metab; 2010 Aug; 12(8):716-21. PubMed ID: 20590749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy.
    Johannes CB; Koro CE; Quinn SG; Cutone JA; Seeger JD
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):504-12. PubMed ID: 17245800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.